[Diagnostic molecular biology in solid tumors--thyroid gland]

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Thyroid cancer presents diverse clinical and molecular characteristics.
• Specific genetic alterations define different thyroid tumor subtypes, including TSH-receptor mutations and RET proto-oncogene rearrangements in follicular and papillary carcinomas.
• Undifferentiated thyroid tumors are associated with p53 mutations.

Purpose of the Study:

• To review the molecular basis of various thyroid tumor types.
• To highlight the limited impact of current molecular knowledge on clinical practice.
• To discuss the implications of genetic findings in familial medullary thyroid cancer.

Main Methods:

• Literature review of thyroid cancer genetics and molecular pathology.
• Analysis of mutations and gene expression patterns in different thyroid tumor categories.
• Examination of familial cancer syndromes related to thyroid neoplasms.

Main Results:

• Follicular and papillary thyroid carcinomas are characterized by TSH-receptor mutations, RET rearrangements, and altered tyrosine kinase receptor expression.
• Undifferentiated thyroid tumors frequently exhibit p53 mutations.
• Germ-line RET mutations are identified in familial medullary thyroid carcinoma cases.

Conclusions:

• Current molecular insights into thyroid cancer have expanded understanding but not significantly improved diagnostics or treatments.
• Identification of germ-line RET mutations in familial medullary thyroid cancer enables prophylactic thyroidectomy.
• Further research is needed to translate molecular discoveries into effective clinical strategies for most thyroid cancers.